Our platform provides reliable cellular tools for evaluating agonists targeting key co-stimulatory pathways. Available models include OX40, 4-1BB, GITR, CD27, HVEM/LIGHT, CD28, and BTLA, engineered with reporter systems to quantify pathway-specific activation. These standardized assays enable robust potency and efficacy assessment, accelerating the development of next-generation immunostimulatory therapeutics.
